US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.55

-20.7555-2.91%

Number of Gainers:37

Number of Losers:104

Number of Flat:12

PE:- -

High:711.28

Open:710.98

Low:683.06

Close:714.31

Volume:396.89M

Turnover:13.64B

Market Cap:481.28B

Float Cap:365.81B

Loading ...

Robinhood Markets Price Target Raised to $145.00/Share from $135.00 by Piper Sandler

Climb Bio's CLYM116 Data Could Show Competitive Position in IgA Nephropathy Market, Oppenheimer Says

MT Newswires Live

Sprinklr, Inc. Reports Results for the Quarter Ended April 30 - Earnings Summary

TScan Therapeutics Inc : Wedbush Cuts to Neutral from Outperform; Cuts Target Price to $1 from $5

THOMSON REUTERS

Sprinklr Slips on Downbeat Annual Forecast

Ipsidy Announces CEO Transition and Strategic Leadership Changes

HCW Biologics receives patent allowance for alopecia areata drug

Sector Update: Tech Stocks Lean Lower Premarket Wednesday

MT Newswires Live

HCW Biologics Wins USPTO Patent Allowance for Hcw9302 Use in Alopecia Areata Treatment

Authid Names CTO Thomas Szoke Interim CEO as Rhoniel Daguro Resigns CEO Role

Eco Wave Power Partners with AI Engineering to Develop AI-Powered Digital Twin Platform for Wave Energy

Authid - Appoints Thomas R. Szoke as Interim CEO Effective September 4, 2026 - SEC Filing

THOMSON REUTERS

Authid - Rhoniel A. Daguro Resigns as CEO Effective September 4, 2026 - SEC Filing

THOMSON REUTERS

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

Duolingo (DUOL) Gets a Hold from J.P. Morgan

dLocal Partners with Alternative Airlines to Add BNPL Payments for Travel Bookings in Emerging Markets

Edgewise Therapeutics Grants Inducement Equity Awards Covering 31,501 Shares to New Hires

Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules

THOMSON REUTERS

Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference

Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK4539/news?page=42"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.54956,"timestamp":1789502399999,"preClose":714.30505,"halted":0,"volume":396887720,"delay":0,"changeRate":-0.029057,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-20.755493,"latestTime":"09-15 16:00:00 EDT","open":710.9754,"high":711.27765,"low":683.0616,"amount":13642859620.161587,"amplitude":0.039501,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.340053,"peRate":116.830865,"turnoverRate":0.031034,"increases":37,"decrements":104,"flats":9,"marketCap":481283882916.5,"floatMarketCap":365812905933.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":711.27765,"amplitude":0.039501,"preClose":714.30505,"low":683.0616,"pbRate":"5.340053","latestPrice":693.54956,"volume":396887720,"delay":0,"open":710.9754,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":705.7056,"twentyDayClose":666.772,"sixtyDayClose":727.8837,"secType":"PLATE","market":"US","turnoverRate":0.031034,"peRate":116.830865,"marketCap":481283882916.5,"floatMarketCap":365812905933.625,"timestamp":1789502399999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":37,"down":104,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:42,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664843506","title":"Robinhood Markets Price Target Raised to $145.00/Share from $135.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843506?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:40","pubTimestamp":1788367200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HOOD/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOG","BLCK","CRPT","IAI","HOOY","BK4547","BK4539","HOOX","FINX","BPAY","LU1861559042.SGD","HOII","BK4127","HOOC","HOOI","LU1861558580.USD","HOYY","HODU","HOOD","HOOW","ROBN","HOOZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664756848","title":"Climb Bio's CLYM116 Data Could Show Competitive Position in IgA Nephropathy Market, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664756848","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664756848?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:12","pubTimestamp":1788365551,"startTime":"0","endTime":"0","summary":"Climb Bio's  CLYM116 could stand out in the growing IgA nephropathy treatment market if Thursday's phase 1 data shows strong and lasting APRIL and IgA reductions that support less frequent dosing, Oppenheimer said in a note Wednesday.The key question for Thursday's results is whether CLYM116 can deliver strong and durable effects that could support an infrequently administered under-the-skin treatment, Oppenheimer said.The investment firm said other approved and experimental anti-APRIL drugs have already shown that targeting APRIL can work in IgAN, setting a benchmark for CLYM116.The phase 2 portion of partner Mabworks' phase 1/2 IgAN study is expected to begin before the end of the quarter, with Climb Bio planning to present additional CLYM116 data at a medical meeting in Q4, the firm noted.Oppenheimer kept its outperform rating and $18 price target for Climb Bio.Price: 14.62, Change: -0.21, Percent Change: -1.38","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664174368","title":"Sprinklr, Inc. Reports Results for the Quarter Ended April 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2664174368","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664174368?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:26","pubTimestamp":1788359206,"startTime":"0","endTime":"0","summary":"Sprinklr, Inc. reports results for the quarter ended April 30 - Earnings SummarySprinklr, Inc.CXM.Nreported quarterly adjusted earnings of 11 cents per share for the quarter ended April 30, lower than","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL8N44U1L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CXM","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664958817","title":"TScan Therapeutics Inc : Wedbush Cuts to Neutral from Outperform; Cuts Target Price to $1 from $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2664958817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664958817?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:17","pubTimestamp":1788358652,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664161812","title":"Sprinklr Slips on Downbeat Annual Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664161812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664161812?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:40","pubTimestamp":1788356432,"startTime":"0","endTime":"0","summary":"BUZZ-Sprinklr slips on downbeat annual forecast** Shares of enterprise software company SprinklrCXM.Nfall 2.4% to $7.4** CXMexpectsFY27 adj. EPS of about 47 cents, below analysts' estimates of 49 cents - data compiled by LSEG** Co sees Q3 adj. EPS of 11cents, below estimates of 13 cents** Posts Q2 revenue $213.74 mln, slightly below estimates of $214.4 mln** 8 of 9 brokerages rate the stock \"buy\" or higher and 1 \"hold\"; median PT is $6.75 - LSEG data** Including session's moves, stock down 5.3% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL6N44U0W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CXM","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664121958","title":"Ipsidy Announces CEO Transition and Strategic Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664121958","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664121958?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:27","pubTimestamp":1788355621,"startTime":"0","endTime":"0","summary":"Ipsidy ( ($AUID) ) has issued an update. On August 26, 2026, Ipsidy’s Chief Executive Officer Rhoniel A. Daguro tendered his resignation, effective...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ipsidy-announces-ceo-transition-and-strategic-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ipsidy-announces-ceo-transition-and-strategic-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4539","AUID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812486","title":"HCW Biologics receives patent allowance for alopecia areata drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812486?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:20","pubTimestamp":1788355222,"startTime":"0","endTime":"0","summary":"HCW Biologics (HCWB) announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for claims directed to use of HCW9302 to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hcw-biologics-receives-patent-allowance-for-alopecia-areata-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hcw-biologics-receives-patent-allowance-for-alopecia-areata-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCWB","USRD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814710","title":"Sector Update: Tech Stocks Lean Lower Premarket Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814710","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814710?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:10","pubTimestamp":1788354635,"startTime":"0","endTime":"0","summary":"Technology stocks were leaning lower premarket Wednesday, with the State Street Technology Select Sector SPDR Fund  declining by 0.3% and the State Street SPDR S&P Semiconductor ETF  down 0.1%.Dell Technologies  stock was up more than 9% after the company posted higher fiscal Q2 non-GAAP adjusted earnings and revenue, and raised its fiscal 2027 guidance.Hewlett Packard Enterprise  has expanded its partnership with Tottenham Hotspur Football Club to modernize the technology infrastructure for the club's stadium, including hybrid cloud, networking and artificial intelligence-driven operations, Tottenham said. Shares of Hewlett Packard Enterprise were up more than 3% pre-bell.Sprinklr  shares were down more than 5% after the company reported a decline in fiscal Q2 adjusted earnings and cut its fiscal 2027 adjusted EPS outlook.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525689.USD","LU0211326839.USD","XLK","XSD","LU0267386448.USD","BK4585","HPE","HPEL","BK4543","BK4539","CXM","LU0985481810.HKD","LU0225284248.USD","BK4515","DLLL","LU0225771236.USD","LU0052756011.USD","LU2065171402.SGD","LU0345770993.USD","LU2065171311.SGD","LU1235294995.USD","BK4535","LU0321505439.SGD","LU0310800965.SGD","LU1267930227.SGD","LU1823568750.SGD","LU0306806265.USD","LU0976567544.SGD","LU2065170008.USD","LU0211326755.USD","LU0345770308.USD","LU0306807586.USD","LU2065169927.USD","LU0006061336.USD","LU0348723411.USD","BK4023","BK4588","LU1046421795.USD","LU1804176565.USD","LU0496365809.HKD","WLDR","DELL","FXL","LU2265009873.SGD","BK4170","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781443","title":"HCW Biologics Wins USPTO Patent Allowance for Hcw9302 Use in Alopecia Areata Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781443","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781443?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:03","pubTimestamp":1788354187,"startTime":"0","endTime":"0","summary":"HCW Biologics wins USPTO patent allowance for HCW9302 use in alopecia areata treatmentHCW Biologics received a USPTO notice of allowance for patent claims covering use of HCW9302 to treat alopecia are","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL42Dztr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","SG9999014013.SGD","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4112","BK4139","LU0314104364.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","LU2095319765.USD","BCDF","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4539","HCWB","BK4585","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664233811","title":"Authid Names CTO Thomas Szoke Interim CEO as Rhoniel Daguro Resigns CEO Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233811","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664233811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:33","pubTimestamp":1788352408,"startTime":"0","endTime":"0","summary":"Authid names CTO Thomas Szoke interim CEO as Rhoniel Daguro resigns CEO roleAuthid named co-founder and Chief Technology Officer Thomas R. Szoke interim CEO effective Sept. 4, 2026.Szoke has 35+ years","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL8xqSJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","AUID","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811444","title":"Eco Wave Power Partners with AI Engineering to Develop AI-Powered Digital Twin Platform for Wave Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811444","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811444?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352342,"startTime":"0","endTime":"0","summary":"Eco Wave Power partners with AI engineering to develop AI-powered digital twin platform for wave energyEco Wave Power’s U.S. unit entered an agreement with Germany’s AI engineering to build an AI-powe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL32wNvz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0187121727.USD","LU2458330243.SGD","LU0823421416.USD","LU0274383776.USD","CHAT","IE00B3M56506.USD","LU0198837287.USD","LU2133065610.SGD","TEK","LU1935043023.USD","LU0154236417.USD","LU0323591593.USD","LU0316494557.USD","LU0289960550.SGD","LU2279689827.SGD","IE000KEQY171.SGD","LU1035775433.USD","LU2065171402.SGD","LU1934455863.HKD","LU2242649171.HKD","LU1232071149.USD","BK4612","LU2237443622.USD","LU0882574139.USD","LU1261432733.SGD","LU0133085943.USD","BK4548","LU1066051498.USD","SGXZ51526630.SGD","LU2322448791.USD","LU2089284900.SGD","LU2361044949.HKD","LU2413666426.HKD","IE0034235303.USD","LU2360032135.SGD","LU2473716301.USD","ESLG","LU1069344957.HKD","LU1814569148.SGD","LU0912757837.SGD","SNVD.UK","LU2347655073.USD","LU0683600562.USD","LU2125154935.USD","LU1778281490.HKD","LU2089985449.USD","LU2756315318.SGD","LU0985320562.USD","LU0823434740.USD","LU2237443465.HKD","SG9999014542.SGD","LU0056508442.USD","HK0000914660.USD","LU2462157665.USD","SOXX","LU2097344431.USD","LU0861579265.USD","SG9999002232.USD","IE00BD6J9T35.USD","IE0034235188.USD","LU1923623000.USD","LU1069347547.HKD","LU1035773651.USD","LU1803068979.SGD","LU0265550946.USD","LU0494093205.USD","LU2491050154.USD","IE00BMPRXR70.SGD","SG9999015341.SGD","LU2028103732.USD","HK0000306701.USD","LU0210533765.USD","LU0642271901.SGD","LU1267930490.SGD","LU0528227936.USD","LU1202635105.USD","LU0061475181.USD","LU1244550577.SGD","METV","IE0004091025.USD","IE00B775H168.HKD","LU2100268510.USD","LU2360107168.USD","BK4585","LU2237443382.USD","LU0868494708.USD","LU1242518931.SGD","FTEC","SG9999004303.SGD","LU0124676726.USD","LU0127658192.USD","LU0210536198.USD","LU0949170772.SGD","LU2125909247.SGD","LU2125154778.USD","USXF","IE00BK4W5M84.HKD","LU1066051811.HKD","LU0011850046.USD","HK0000532082.HKD","LU0444971666.USD","LU0203202063.USD","LU1571399168.USD","LU1316542783.SGD","LU1642822529.SGD","LU1721428933.USD","07788","LU2286300806.USD","LU0308772762.SGD","SG9999014575.USD","LU1992135399.USD","LU2168564495.EUR","HK0000304805.HKD","LU0158827781.USD","LU2860962120.EUR","LU1629891620.HKD","SGXZ99366536.SGD","LU0234570918.USD","LU1720051108.HKD","LU1861220033.SGD","IE00BN29S564.USD","HK0000819398.USD","LU0965509101.SGD","SGXZ80539844.SGD","LU0672654240.SGD","NVDL","LU0511384066.AUD","LU2896262040.SGD","EFIV","NVDD","LU0708994859.HKD","LU2463028550.USD","BK4587","IE00B1XK9C88.USD","IE00BJTD4V19.USD","LU2237957811.SGD","IE00BWXC8680.SGD","BK4605","HK0000306685.HKD","ANV","LU1861127337.USD","IE00BQXX3D17.EUR","TTEQ","LU2237438978.USD","LU2403377893.USD","LU1934455194.USD","LU0070217475.USD","LU2602419157.SGD","LU2087625088.SGD","LU2242650005.HKD","LU2265009873.SGD","LU0347712357.USD","LU0661504455.SGD","LU1144417596.USD","IXN","IE00B7KXQ091.USD","LU0965509010.AUD","AGOX","LFGY","LU2237443549.SGD","WAVE","LU0266013472.USD","LU0289739343.SGD","ROM","LU2491049909.HKD","LU1880398554.USD","LU1037948897.HKD","LU2552382058.USD","LU1988902786.USD","LU0820561909.HKD","LU1992135472.HKD","IE000Q6AESB8.SGD","BK4579","IE0001KFT4U8.USD","SG9999014880.SGD","LU0097036916.USD","DIPS","LU0689626769.HKD","NULC","LU0109391861.USD","LU2244417387.USD","LU2168564065.EUR","LU2394011477.USD","LU1923622291.USD","IE00BMPRXQ63.HKD","LU2168563687.JPY","LU1066053197.SGD","LU1868836914.USD","IE00BMPRXN33.USD","IE00B19Z9505.USD","ESUM","LU2111349929.HKD","LU0082616367.USD","IE000YTNTUN2.SGD","LU0979878070.USD","LU0795875169.SGD","LU2092937148.SGD","LU0708995401.HKD","LU2272731865.HKD","LU1400636491.USD","LU0225283273.USD","LU2381873111.SGD","LU0353189763.USD","LU0820561818.USD","LU2083900584.USD","LU1718418525.SGD","IE000ITXATA3.USD","LU2272731600.USD","LU2264538146.SGD","BK4567","LU2552382215.SGD","LU1815336760.USD","LU1323610961.USD","LU2023250330.USD","JGRO","IE0004445015.USD","LU2106854487.HKD","IE00BJTD4N35.SGD","BK4554","LU1923622614.USD","LU2430703095.HKD","LU2237443895.HKD","THMR","LU2077746001.SGD","LU0823414551.USD","LU0557290698.USD","LU0957791311.USD","IE00BDRTCR15.USD","LU0323239441.USD","LU0238689110.USD","LU1400636574.HKD","LU2047632596.USD","IE00B5TLWC47.USD","IE00BKDWB100.SGD","LU0077335932.USD","LU1366333091.USD","LU1244550221.USD","LU2272731782.SGD","NVC","LU0094547139.USD","LU2746668461.USD","NVDY","CNEQ","LU1732799900.SGD","IE0004086264.USD","LU1989772923.USD","LU0323240290.USD","LU0289961442.SGD","LU0553294199.USD","LU2092627202.USD","SG9999015978.USD","LU0234572021.USD","LU0345770308.USD","LU2237957902.USD","SG9999015945.SGD","BK4527","LU0210528500.USD","SGXZ81514606.USD","LU0444973449.USD","IE0034235295.USD","LU2637965513.SGD","NVD","GB00BDT5M118.USD","LU2087621335.USD","LU1989772840.SGD","LU1623119135.USD","SG9999000418.SGD","LU0738911758.USD","SOXQ","VGT","CLSE","CHPX","IE00BQXX3C00.GBP","LU2430703251.USD","IE00BK4W5L77.USD","NVDG","LU2065169927.USD","CMAG","LU1804176565.USD","LU2294711713.HKD","LU2168564222.USD","LU0689472784.USD","LU0726765562.USD","LU0048584097.USD","BK4592","LU1435385759.SGD","BK4614","09788","AIPI","LU1935043536.SGD","LU0256863902.USD","LU2505996509.AUD","LU0138981039.USD","LU0175139822.USD","LU0889565833.HKD","LU1852331112.SGD","LU0203201768.USD","LU2108987350.USD","LU0390134368.USD","LU0640476718.USD","LU2148611432.USD","IE00BZ1G4Q59.USD","LU0053666078.USD","LU1861215975.USD","LU0096364046.USD","IE00B775SV38.USD","LU2361044865.SGD","LU0109392836.USD","IE00BKPKM429.USD","LU0170899867.USD","SG9999015952.SGD","LU2471134523.USD","LU1791710400.SGD","LU1400636657.SGD","IE00B4YYXB79.USD","SG9999014906.USD","LU2360106780.USD","LU0868494617.USD","LU2420271590.USD","LU0057025933.USD","LU1917777945.USD","BK4503","LU1084165304.USD","WISE","LU0310800379.SGD","09388","LU2249611893.SGD","LU0545039389.USD","LU1839511570.USD","LU2357305700.SGD","LU1003077747.HKD","LU2089283258.USD","LU0942090050.USD","LU2999663052.SGD","NVDU","LU1496350502.SGD","LU2413666699.HKD","BK4551","LU0965509283.SGD","LU1934455277.USD","ILDR","SG9999017495.SGD","LU2271345857.HKD","LU2417539215.USD","HK0000320223.HKD","LU1267930573.SGD","LU2746668974.SGD","LU2357125470.USD","LU0823434583.USD","LU2430703178.SGD","SG9999015358.SGD","SG9999018857.SGD","LU0128525929.USD","SNVDAmain","LU1066051225.USD","LU1951198990.SGD","ARTY","NVDS","LU2191332357.HKD","LU0143551892.USD","LU0466842654.USD","BK4608","BK4133","LU1153585028.USD","IE00B19Z8W00.USD","LU0211327993.USD","LU0158827948.USD","LU0320765059.SGD","LU1868836757.USD","NVDB","NVDS.UK","LU2054465674.USD","BK4529","NVD2.UK","LU1127390331.HKD","NVDX","SHOC","LU2756315664.SGD","IE0004445239.USD","LU1720051017.SGD","SGXZ31699556.SGD","TYLG","HK0000304797.USD","LU0348723411.USD","LU2213496289.HKD","NVDA","BK4543","LU0719512351.SGD","LU1670756490.USD","LU2471134796.USD","LU0081259029.USD","IE00BQXX3F31.USD","LU2487616109.SGD","LU0276348264.USD","LU1989764748.USD","LU1645745479.HKD","LU2168564149.EUR","IE00BFSS7M15.SGD","LU0174119429.USD","BK4581","LU1699723380.USD","SG9999014559.SGD","HK0000320264.USD","LU0345768153.USD","LU0211328371.USD","LU0345768740.USD","LU2452424414.USD","LU2462591277.SGD","BK4549","SG9999001424.SGD","LU0215105999.USD","LU0069063385.USD","LU0310799852.SGD","LU0823421333.USD","LU2326559502.SGD","LU1868836591.USD","IE00B1BXHZ80.USD","LU1935042488.USD","LU2505996681.GBP","LU1366192091.USD","LU1633808545.USD","LU1116320737.USD","IE00BJJMRX11.SGD","LU2237443978.SGD","LU0080751232.USD","BK4550","SPTE","BK4533","LU2462591350.SGD","LU2236285917.USD","LU1935042991.SGD","LU1242518857.USD","LU2491050071.SGD","LU1037948541.HKD","HK0000914686.HKD","LU0029864427.USD","LU2097344357.USD","LU2125909916.SGD","LU0079474960.USD","LU0345769128.USD","IE00B19Z8X17.USD","LU0395794307.EUR","LU1674673691.USD","07388","LU2458330169.SGD","IE0003U64NQ7.SGD","IE0009356076.USD","LU0354030438.USD","SG9999015986.USD","LU0823414478.USD","LU1119994496.HKD","LU1548497426.USD","LU2592432038.USD","LU0107464264.USD","TTXU","NVDO","BK4532","LU0788109477.HKD","IE00BDCRKT87.USD","IE00B4JS1V06.HKD","LU2023250504.SGD","LU1064131342.USD","TRFK","NVII","IE00BYXW3230.USD","LU1267930730.SGD","LU1791710582.SGD","LU2065171311.SGD","LU2931357623.SGD","LU1712237335.SGD","LU0256863811.USD","AIFD","SG9999014898.SGD","IE00BHPRN162.USD","LU1880398471.USD","LU1983260115.SGD","LU2211815571.USD","LU2543165471.USD","3NVD.UK","IE00B3S45H60.SGD","LU2750360997.AUD","USD","LU1496350171.SGD","LU2471134879.HKD","2NVD.UK","IE00B3SWFQ91.USD","LU1821325948.USD","LU2954938101.SGD","SMH","LU2750360641.GBP","LU2065170008.USD","LU1551013425.SGD","LU0096362180.USD","LU2433249047.HKD","IETC","NVYY","LU0342679015.USD","LU1429558221.USD","LU0417517546.SGD","SOXY","LU1674673428.USD","LU0106261372.USD","LU1145028129.USD","LU0345770993.USD","LU1974910355.USD","LU1244550494.USD","NVIW.SI","SG9999002224.SGD","LU1691799644.USD","LU0006306889.USD","XLK","LU0472753341.HKD","LU2461242641.AUD","LU2125909759.SGD","LU0957808578.USD","LU0354030511.USD","LU2023251221.USD","VT","LU2290526834.HKD","BK4141","LU1116320901.HKD","LU0820562030.AUD","LU0724617625.USD","LU2063271972.USD","LU0157215616.USD","LU1280957306.USD","LU2361045086.USD","LU1935042215.USD","ABFL","FDTX","IE000W1ABFV2.USD","LU0787776722.HKD","SG9999014567.USD","SMHX","SNPE","LU0964807845.USD","LU0353189680.USD","LU0795875086.SGD","LU2125909593.SGD","LU1951200564.SGD","LU2322448957.HKD","LU0061474705.USD","LU1868837136.USD","IE0009G5SDU7.USD","LU0265550359.USD","BK4588","SGXZ23171101.USD","LU0786609619.USD","LU2552382132.HKD","IE00BFSS8Q28.SGD","LU1914381329.SGD","LU0061474960.USD","LU3102509885.SGD","LU1732800096.USD","LU1868837300.USD","NVD3.UK","SG9999014914.USD","LU0345769631.USD","LU0251132253.USD","IE0005OL40V9.USD","BK4534","LU0072462426.USD","LU0476273544.USD","LU2247934214.USD","LU1551013342.USD","LU2250418816.HKD","SG9999018865.SGD","IE00BZ199S13.USD","LU0267386448.USD","IE00B5949003.HKD","LU0965508806.USD","LU1989764664.SGD","NVDQ","LU2506951792.HKD","FAI","LU2456880835.USD","LU2471134952.CNY","LU0943347566.SGD","IE00BJLML261.HKD","NVDW","BK4598","GAMR","LU1815333072.USD","LU1979441026.SGD","IE00BJJMRY28.SGD","BK4539","LU2347655156.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811484","title":"Authid - Appoints Thomas R. Szoke as Interim CEO Effective September 4, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811484","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811484?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:31","pubTimestamp":1788352308,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T1AR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AUID","BK4539","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811481","title":"Authid - Rhoniel A. Daguro Resigns as CEO Effective September 4, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811481","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811481?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:31","pubTimestamp":1788352308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T1AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","AUID","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811229","title":"Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811229","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811229?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (Allo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355132/0/en/allogene-therapeutics-announces-retirement-of-chief-financial-officer-geoffrey-parker.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664116628","title":"Duolingo (DUOL) Gets a Hold from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664116628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664116628?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:19","pubTimestamp":1788351542,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Bryan Smilek from J.P. Morgan maintained a Hold rating on Duolingo, with a price target of $135.00. The company’s s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/duolingo-duol-gets-a-hold-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/duolingo-duol-gets-a-hold-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4539","DUOG","DUOL","BK4204","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581973","title":"dLocal Partners with Alternative Airlines to Add BNPL Payments for Travel Bookings in Emerging Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581973","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581973?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:05","pubTimestamp":1788350751,"startTime":"0","endTime":"0","summary":"dLocal partners with Alternative Airlines to add BNPL payments for travel bookings in emerging marketsdLocal partnered with Alternative Airlines to add buy-now-pay-later options for flight bookings ac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2QR87m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4539","BK4227","DLO","BK4585","BK4563","BK4106"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881914","title":"Edgewise Therapeutics Grants Inducement Equity Awards Covering 31,501 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881914?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350425,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics grants inducement equity awards covering 31,501 shares to new hiresEdgewise Therapeutics granted inducement equity awards to four new non-executive employees on Aug. 31, 2026.Sto","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL6yP9rz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EWTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664191808","title":"Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2664191808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664191808?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA1SNHZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819046","title":"Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819046","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819046?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355075/0/en/acrivon-therapeutics-to-present-at-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","XBI","LABU","BK4007","BK4139","BK4588","LU0128526141.USD","HCSG","XLV","BK4137","BK4581","LENZ","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819044","title":"Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819044?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355100/0/en/design-therapeutics-to-participate-in-2026-cantor-fitzgerald-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLV","LU0128526141.USD","BK4585","BK4137","DSGN","XBI","LU0029874061.USD","BK4581","BK4505","BK4539","HCSG","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":42,"totalSize":881,"code":"91000000","status":"200"}]}}